| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |